Company: IMV Inc.
Job title: Head of Business Development
The DPX Delivery Platform Enables Cancer Vaccines to be Clinically Viable 10:30 am
DPX is a unique lipid-in-oil, non-emulsion delivery formulation that educates a targeted and long-lasting immune response in regional lymph nodes DPX can be formulated to deliver a variety of cargo (e.g. peptides, proteins, VLPs, TLRs, mRNA) Proof of concept is clinically demonstrated in several hematologic and solid cancer indicationsRead more
day: Day One